metformin and rapamycin (MetRapa)
rapamycin (aka sirolimus), oral
Often cited as the available molecule with the broadest & most consistent evidence of meaningful benefit for aging. Viewed by some as a CR mimetic.
acarbose
17-alpha estradiol
Rodent lifespan extension results are in males, so this is a separate row from HRT for women, which has very different kinds of data justifying it.
SGLT2 inhibitors (eg Canagliflozin)
Top scoring candidate for TAME-like trial (see gerotherapeutics score column).
ACE inhibitors (eg captopril) & ARBs
nordihydroguaiaretic acid (NDGA) - Male only, Stage II
astaxanthin
nordihydroguaiaretic acid (NDGA)
16 alpha-hydroxyestradiol
Meclizine (Mec)
17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride (DMAG)
rapamycin (Rapa) - Intermittent, Stage II
1,3-butanediol (BD)
Halofuginone (Hal)
MSDC-160 (M160)
Forskolin (For)
aspirin
Mitoglitazone (M160)
metformin
Considered at one time to be the safest aging therapeutic with likely widespread benefit. Intended molecule of TAME multimorbidity trial.
ursodeoxycholic acid (UDCA)
Protandim (Prot)
resveratrol
fisetin
Supplement with the most evidence of senolytic effect, with many ongoing clinical trials at Mayo.
ursolic acid (UA)
Syringaresinol (Syr)
Pioglitazone (Pio)
Epicatechin (Epi)
green tea extract (GTE)
minocycline (Min)
geranylgeranyl acetone (GGA)
Hydralazine
2,4-Dinitrophenol (DNP)
Atorvastatin + Telmisartan (AtorTel)
statins
nitroflurbiprofen (NFP)
oxaloacetic acid (OAA)
candesartan cilexetil (CC)
3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one (MIF098)
Methotrexate
alpha ketoglutarate (AKG), eg Rejuvant
curcumin / tumeric
4-OH-a-phenyl-N-tert-butyl nitrone (4-OH-PBN)
4-Phenylbutyrate (PBA)
caffeic acid phenethyl ester (CAPE)
Dichloroacetate (DCA)
Hydrogen Sulfide prodrug SG1002
2-(2-Hydroxyphenyl)benzoxazole (HBX)
Dimethyl Fumarate (DMF)
Mycophenolic Acid (MPA)
Sodium Thiosulfate (STS)
L-Leucine (Leu)
Mifepristone (Mife)
medium-chain triglyceride oil (MCTO)
b-guanidinopropionic acid (bGPA)
inulin (Inu)
methylene blue
NAD+ precursors: eg NMN, NR
Big business. Possibly the most widely used aging-related supplements. Many papers & dozens of clinical trials, but also much controversy.
INT-767 FXR/TGR5 agonist (INT-767)
PB125
Sulindac (Sul)
2BAct (2BA)
beta blockers
TM5441 (TM5441)
CSM-101
Preclinical TRPML1 agonist designed to restore lysosomal function in genetically driven Parkinson's-related disorders.
GLP-1 agonists
Dasatinib + quercetin (D+Q)
Arguably the available rejuvenation therapy with the best available evidence currently.
PDE5 inhibitors, eg Viagra/sildenafil, Cialis/tadalafil
ginger
diet (umbrella for many mods): calorie restriction (CR), protein restriction (PR), 1-amino restriction (eg methionine), fasting, intermittent fasting (IF), time restricted feeding (TRF), WFPB/low-fat, keto/low-carb, Mediteranean, DASH, MIND, etc.
By far the most extensive evidence of benefit for any intervention.
berberine
Viewed by some as the supplement most analagous to metformin.
sleep (enough)
Clearly chronic sleep deprivation speeds aging. Don't have time for a lit review myself here---what's the best review or lit survey to cite?
melatonin
HRT for women
taurine
red yeast rice / monaclins (naturally occuring statin lovastatin)
GlyNAC (glycine + N-acetylcysteine) or NAC
Precursor to glutathione so see also that row.
glutathione
NAC is a precursor so see also that row.
sun exposure
bisphosphonates
bariatric surgeries for people w/ obesity
glucosamine
chondroitin sulfate
whole blood donation
ashwagandha
plasma donation or TPE (therapeutic plasma exchange)
plasmalogens
Unvetted 2025 webpage writeup.
C15:0 aka fatty15 aka pentadecanoic acid
choline, also meclofenoxate (aka centrophenoxine)
Maybe should separate these eventually.
apigenin
omega3s: fish oil, algal oil, flax (DHA, EPA, ALA)
red/NIR/IR light/photobiomodulation therapy
probiotics / prebiotics supplements
green tea extract / EGCG
testosterone for men
EDTA chelation therapy
acoramidis (Attruby)
TTR stabilizer made by Eidos Tx, which was acquired by BridgeBio, approved for ATTR-CM.
patisiran (Onpattro)
RNAi drug to reduce TTR production made by Alnylam, approved for hATTR.
inotersen (Tegsedi)
ASO (anti-sense oligonucleotide) to reduce TTR production made by Akcea Therapeutics, which was acquired by Ionis Pharmaceuticals, approved for hATTR.
| Select up to four records | ||||||
|---|---|---|---|---|---|---|
| Rapamycin + Acarbose (RaAc) - Stage II | small molecule | rate-of-aging | Yes | 37.00 | 28.00 | |
| metformin and rapamycin (MetRapa) | small molecule | rate-of-aging | Yes | 23.00 | 23.00 | |
| rapamycin (aka sirolimus), oral Often cited as the available molecule with the broadest & most consistent evidence of meaningful benefit for aging. Viewed by some as a CR mimetic. | drug | age slowing | Yes | 22.00 | 28.00 | |
| acarbose | drug | age slowing | Yes | 22.00 | 5.00 | |
| 17-alpha estradiol Rodent lifespan extension results are in males, so this is a separate row from HRT for women, which has very different kinds of data justifying it. | hormone | — | Yes | 19.00 | 1.00 | |
| SGLT2 inhibitors (eg Canagliflozin) Top scoring candidate for TAME-like trial (see gerotherapeutics score column). | drug | age slowing | Yes | 14.00 | 1.00 | |
| ACE inhibitors (eg captopril) & ARBs | drug | — | Yes | 14.00 | 5.00 | |
| nordihydroguaiaretic acid (NDGA) - Male only, Stage II | small molecule | rate-of-aging | Yes | 12.00 | — | |
| astaxanthin | supplement | — | Yes | 12.00 | 3.00 | |
| nordihydroguaiaretic acid (NDGA) | small molecule | rate-of-aging | Yes | 12.00 | 1.00 | |
| 16 alpha-hydroxyestradiol | small molecule | rate-of-aging | Yes | 9.30 | -6.50 | |
| Meclizine (Mec) | small molecule | rate-of-aging | Yes | 9.20 | 3.00 | |
| 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride (DMAG) | small molecule | rate-of-aging | Yes | 9.00 | -4.00 | |
| rapamycin (Rapa) - Intermittent, Stage II | small molecule | rate-of-aging | Yes | 9.00 | 8.00 | |
| 1,3-butanediol (BD) | small molecule | rate-of-aging | Yes | 9.00 | 1.00 | |
| Halofuginone (Hal) | small molecule | rate-of-aging | Yes | 8.80 | 0.20 | |
| MSDC-160 (M160) | small molecule | rate-of-aging | Yes | 8.70 | -2.30 | |
| Forskolin (For) | small molecule | rate-of-aging | Yes | 8.30 | 0.80 | |
| aspirin | OTC drug | — | Yes | 8.00 | 1.00 | |
| Mitoglitazone (M160) | small molecule | rate-of-aging | Yes | 7.80 | -5.80 | |
| metformin Considered at one time to be the safest aging therapeutic with likely widespread benefit. Intended molecule of TAME multimorbidity trial. | drug | age slowing | Yes | 7.00 | 0.00 | |
| ursodeoxycholic acid (UDCA) | small molecule | rate-of-aging | Yes | 7.00 | -1.00 | |
| Protandim (Prot) | small molecule | rate-of-aging | Yes | 7.00 | 3.00 | |
| resveratrol | supplement | age slowing | Yes | 7.00 | 4.00 | |
| fisetin Supplement with the most evidence of senolytic effect, with many ongoing clinical trials at Mayo. | supplement | rejuvenation | Yes | 7.00 | 1.00 | |
| ursolic acid (UA) | small molecule | rate-of-aging | Yes | 6.00 | 0.00 | |
| Syringaresinol (Syr) | small molecule | rate-of-aging | Yes | 6.00 | -2.00 | |
| Pioglitazone (Pio) | small molecule | rate-of-aging | Yes | 5.70 | -4.40 | |
| Epicatechin (Epi) | small molecule | rate-of-aging | Yes | 5.30 | -2.20 | |
| green tea extract (GTE) | small molecule | rate-of-aging | Yes | 5.00 | 7.00 | |
| minocycline (Min) | small molecule | rate-of-aging | Yes | 5.00 | -3.00 | |
| geranylgeranyl acetone (GGA) | small molecule | rate-of-aging | Yes | 5.00 | 2.00 | |
| Hydralazine | small molecule | rate-of-aging | Yes | 5.00 | -1.70 | |
| 2,4-Dinitrophenol (DNP) | small molecule | rate-of-aging | Yes | 4.40 | -3.50 | |
| Atorvastatin + Telmisartan (AtorTel) | small molecule | rate-of-aging | Yes | 4.20 | -3.80 | |
| statins | drug | — | Yes | 4.00 | 4.00 | |
| nitroflurbiprofen (NFP) | small molecule | rate-of-aging | Yes | 4.00 | 0.00 | |
| oxaloacetic acid (OAA) | small molecule | rate-of-aging | Yes | 4.00 | 3.00 | |
| candesartan cilexetil (CC) | small molecule | rate-of-aging | Yes | 4.00 | 1.00 | |
| 3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one (MIF098) | small molecule | rate-of-aging | Yes | 4.00 | -1.00 | |
| Methotrexate | small molecule | rate-of-aging | Yes | 3.90 | -0.10 | |
| alpha ketoglutarate (AKG), eg Rejuvant | supplement | ? | Yes | 3.40 | 0.90 | |
| curcumin / tumeric | supplement | — | Yes | 3.00 | 5.00 | |
| 4-OH-a-phenyl-N-tert-butyl nitrone (4-OH-PBN) | small molecule | rate-of-aging | Yes | 3.00 | -4.00 | |
| 4-Phenylbutyrate (PBA) | small molecule | rate-of-aging | Yes | 3.00 | -2.00 | |
| caffeic acid phenethyl ester (CAPE) | small molecule | rate-of-aging | Yes | 3.00 | 5.00 | |
| Dichloroacetate (DCA) | small molecule | rate-of-aging | Yes | 2.50 | -0.50 | |
| Hydrogen Sulfide prodrug SG1002 | small molecule | rate-of-aging | Yes | 2.00 | 1.00 | |
| 2-(2-Hydroxyphenyl)benzoxazole (HBX) | small molecule | rate-of-aging | Yes | 1.00 | -2.00 | |
| Dimethyl Fumarate (DMF) | small molecule | rate-of-aging | Yes | 1.00 | 0.00 | |
| Mycophenolic Acid (MPA) | small molecule | rate-of-aging | Yes | 1.00 | -1.00 | |
| Sodium Thiosulfate (STS) | small molecule | rate-of-aging | Yes | 0.90 | -0.90 | |
| L-Leucine (Leu) | small molecule | rate-of-aging | Yes | 0.00 | -2.00 | |
| Mifepristone (Mife) | small molecule | rate-of-aging | Yes | -0.50 | -3.60 | |
| medium-chain triglyceride oil (MCTO) | small molecule | rate-of-aging | Yes | -1.00 | 2.00 | |
| b-guanidinopropionic acid (bGPA) | small molecule | rate-of-aging | Yes | -1.00 | -1.00 | |
| inulin (Inu) | small molecule | rate-of-aging | Yes | -2.00 | 2.00 | |
| methylene blue | drug or IV | — | Yes | -2.00 | 1.00 | |
| NAD+ precursors: eg NMN, NR Big business. Possibly the most widely used aging-related supplements. Many papers & dozens of clinical trials, but also much controversy. | supplement | age slowing | Yes | -3.00 | 0.00 | |
| INT-767 FXR/TGR5 agonist (INT-767) | small molecule | rate-of-aging | Yes | -3.00 | -1.00 | |
| PB125 | small molecule | rate-of-aging | Yes | -3.00 | 1.00 | |
| Sulindac (Sul) | small molecule | rate-of-aging | Yes | -3.00 | -2.00 | |
| 2BAct (2BA) | small molecule | rate-of-aging | Yes | -3.40 | -1.50 | |
| beta blockers | drug | — | Yes | -3.40 | -4.20 | |
| TM5441 (TM5441) | small molecule | rate-of-aging | Yes | -4.00 | 0.00 | |
| CSM-101 Preclinical TRPML1 agonist designed to restore lysosomal function in genetically driven Parkinson's-related disorders. | oral CNS-penetrant small-molecule TRPML1 agonist | investigational drug | — | — | — | |
| GLP-1 agonists | drug | age slowing | — | — | — | |
| Dasatinib + quercetin (D+Q) Arguably the available rejuvenation therapy with the best available evidence currently. | drug (+ supplement) | rejuvenation | — | — | — | |
| PDE5 inhibitors, eg Viagra/sildenafil, Cialis/tadalafil | drug | ? | — | — | — | |
| ginger | supplement | — | — | — | — | |
| diet (umbrella for many mods):
calorie restriction (CR), protein restriction (PR), 1-amino restriction (eg methionine), fasting, intermittent fasting (IF), time restricted feeding (TRF), WFPB/low-fat, keto/low-carb, Mediteranean, DASH, MIND, etc. By far the most extensive evidence of benefit for any intervention. | lifestyle mod | age slowing | — | — | — | |
| berberine Viewed by some as the supplement most analagous to metformin. | supplement | age slowing | — | — | — | |
| sleep (enough) Clearly chronic sleep deprivation speeds aging. Don't have time for a lit review myself here---what's the best review or lit survey to cite? | lifestyle mod | age slowing | — | — | — | |
| melatonin | supplement | — | — | — | — | |
| HRT for women | hormone | — | — | — | — | |
| taurine | supplement | — | Yes | — | — | |
| red yeast rice / monaclins (naturally occuring statin lovastatin) | supplement | — | — | — | — | |
| GlyNAC (glycine + N-acetylcysteine) or NAC Precursor to glutathione so see also that row. | supplement | — | — | — | — | |
| glutathione NAC is a precursor so see also that row. | supplement | — | — | — | — | |
| sun exposure | light | — | — | — | — | |
| bisphosphonates | drug | ? | — | — | — | |
| bariatric surgeries for people w/ obesity | surgery | — | — | — | — | |
| glucosamine | supplement | age slowing? | — | — | — | |
| chondroitin sulfate | supplement | — | — | — | — | |
| whole blood donation | blood donation | age slowing | — | — | — | |
| ashwagandha | supplement | ? | — | — | — | |
| plasma donation or TPE (therapeutic plasma exchange) | blood donation | ? | — | — | — | |
| plasmalogens Unvetted 2025 webpage writeup. | supplement | ? | — | — | — | |
| C15:0 aka fatty15 aka pentadecanoic acid | supplement | — | — | — | — | |
| choline, also meclofenoxate (aka centrophenoxine) Maybe should separate these eventually. | supplement | — | — | — | — | |
| apigenin | supplement | — | — | — | — | |
| omega3s: fish oil, algal oil, flax (DHA, EPA, ALA) | supplement | — | — | — | — | |
| red/NIR/IR light/photobiomodulation therapy | light | — | — | — | — | |
| probiotics / prebiotics supplements | supplement | ? | — | — | — | |
| green tea extract / EGCG | supplement | — | — | — | — | |
| testosterone for men | hormone | — | — | — | — | |
| EDTA chelation therapy | IV | — | — | — | — | |
| acoramidis (Attruby) TTR stabilizer made by Eidos Tx, which was acquired by BridgeBio, approved for ATTR-CM. | drug | age slowing | — | — | — | |
| patisiran (Onpattro) RNAi drug to reduce TTR production made by Alnylam, approved for hATTR. | IV | age slowing | — | — | — | |
| inotersen (Tegsedi) ASO (anti-sense oligonucleotide) to reduce TTR production made by Akcea Therapeutics, which was acquired by Ionis Pharmaceuticals, approved for hATTR. | subcutaneous injection | age slowing | — | — | — |